enderdiagnostics.com

What It Is

EMMA by ender diagnostics is a rapid PCR diagnostic solution for bovine mastitis designed for veterinary clinics. Its core selling point is completing sample analysis on-site at the clinic in “90 minutes,” helping veterinarians move from empirical medication to pathogen-based targeted treatment. It is more of a medical/veterinary diagnostic device and testing workflow than a traditional SaaS product. Although the page mentions a customer portal, it does not explain the capabilities of its software platform.

Core Features and Workflow

The workflow is: after a cow shows symptoms of mastitis, the veterinary clinic analyzes a sample using EMMA PCR, then starts more targeted treatment the same day based on the bacterial results. Functionally, it can detect 7 pathogens plus 1 control, analyze up to 8 samples at the same time, provide semi-quantitative results, and highlight its ability to identify hard-to-culture bacteria such as Mycoplasma spp. Built-in process controls are used to verify mechanical disruption of cell walls, DNA release, and PCR integrity, improving confidence in the results. The page also emphasizes that no bacterial culture is required, which can reduce biohazard risk, and that hands-on time is about 15 minutes.

Pricing, Deployment, and Integrations

The page does not disclose plans, device purchase pricing, reagent/consumables costs, subscription fees, or service fees. It only provides a sales contact email and phone number, along with a “try emma now” entry point without explaining trial rules. Based on the description, deployment appears to be on-site testing in clinics. Whether it includes a cloud-based customer portal, report management, integrations with electronic medical records or farm management systems, APIs, or developer support is not disclosed.

Pros and Cons

Its advantages are fast testing, on-site usability, support for up to 8 samples in parallel, and the potential to reduce unnecessary use of broad-spectrum antibiotics. For Gram-negative mastitis scenarios such as E. coli, it can help determine when antibiotics are not needed, thereby reducing milk withdrawal periods, medication costs, and labor costs. The downside is that the public information is fairly marketing-oriented and lacks details on pricing, clinical validation data, regulatory certifications, after-sales service, data security, and the software ecosystem. If evaluated by enterprise software procurement standards, its information transparency is insufficient.

Who It’s For and Access from China

It is suitable for veterinary clinics with a meaningful mastitis caseload, dairy cattle service organizations, and farm veterinary teams looking to optimize antibiotic stewardship. Access and payment information for China is unknown. If deployed in China, additional considerations would include registration of imported diagnostic equipment, reagent supply, after-sales calibration, Chinese-language support, and local compliance. Alternatives include local animal disease testing laboratories, traditional bacterial culture and antimicrobial susceptibility testing, and other veterinary rapid PCR testing devices.